Video

Adherence in Acute Coronary Syndrome

Jeffrey Berger, MD, discusses how research can help increase adherence to therapies among acute coronary syndrome patients.

In this video, from AJMCtv, Jeffrey Berger, MD, assistant professor at NYU Langone Medical Center, discusses how research can help increase adherence to therapies among acute coronary syndrome (ACS) patients.

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.

Subscribe Now!
Related Videos
American Captial Building.
Related Content
FDA waives clinical efficacy studies for certain biosimilars -- Image credit: Kamitana | stock.adobe.com
September 3rd 2025

FDA to Waive Clinical Efficacy Studies for Monoclonal Antibody Biosimilars

Gillian McGovern, Associate Editor
Pharmacy Focus Oncology Edition Podcast
September 3rd 2025

Protecting Community Oncology Practices in the Wake of the IRA

Alexandra Gerlach, Associate Editor
FDA approves 2 denosumab biosimilars, Bildyos and Bilprevda -- Image credit: gguy | stock.adobe.com
September 3rd 2025

FDA Approves Bildyos and Bilprevda, Biosimilars of Reference Denosumab

Gillian McGovern, Associate Editor
From Guidelines to Action: Pharmacy’s Role in Hypertension Management
September 3rd 2025

From Guidelines to Action: Pharmacy’s Role in Hypertension Management

Craig Beavers, PharmD, FACC, FAHA, FCCP, BCCP, BCPSAQ Cardiology, CACP Aislinn Antrim, Managing Editor
Streptococcus pneumoniae, or pneumococcus, is a gram-positive bacteria responsible for many types of pneumococcal infections
September 3rd 2025

A Single Dose of Pneumococcal Conjugate Vaccine Is Effective Against IPD in Children

Luke Halpern, Assistant Editor
Alzheimer disease and lecanemab -- Image credit: HalynaRom | stock.adobe.com
September 3rd 2025

FDA Approves Subcutaneous Lecanemab Injection for Maintenance Dosing in Early Alzheimer Disease

Gillian McGovern, Associate Editor